BKBG
ALXN

BHF Kleinwort Benson Group’s Alexion Pharmaceuticals ALXN Stock Holding History

BHF Kleinwort Benson Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,400
Closed -$162K – 581
2014
Q2 		$162K Sell
1,400
-1,800
-56% -$284K ﹤0.01% 408
2014
Q1 		$196K Buy
+3,200
New +$509K 0.01% 424

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BHF Kleinwort Benson Group's ALXN Position: Q3 2014 in Review

BHF Kleinwort Benson Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2014, closing a stake of 1,400 shares — an estimated $162K sold.

BHF Kleinwort Benson Group first reported a position in ALXN in Q1 2014 and held it in 2 quarters. The position peaked at $196K in Q1 2014. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • BHF Kleinwort Benson Group reported no remaining Alexion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 1,400 Alexion Pharmaceuticals shares in Q3 2014, an estimated $162K.
  • BHF Kleinwort Benson Group first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • BHF Kleinwort Benson Group's Alexion Pharmaceuticals position peaked at $196K in Q1 2014.
  • 522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2014, filed 20 Feb 2015.